Citadel Advisors »

Talis Biomedical Corporation shares owned by Citadel Advisors

Quarter-by-quarter ownership of Talis Biomedical Corporation (TLIS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Talis Biomedical Corporation

Tip: Access up to 7 years of quarterly data

All positions including Talis Biomedical Corporation held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Talis Biomedical Corporation by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 10k 7.45

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Talis Biomedical Corporation

Baker Bros. Advisors
Greenlight Capital
DME Capital Management
BML Capital Management
Vanguard Group
Susquehanna International
Springbok Capital Management
Geode Capital Management
BlackRock
Tower Research Capital
Morgan Stanley
ADAR1 Capital Management
Advisor Group Holdings
UBS Group
Larson Financial Group

View all funds holding Talis Biomedical Corporation